Top compounds associated with response to BSPRY


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel UHNBreast pan-cancer AAC -0.69 0.01
mRNA Bosutinib FIMM pan-cancer AAC -0.57 0.05
mRNA paclitaxel FIMM pan-cancer AAC -0.46 0.0004
mRNA Bortezomib FIMM pan-cancer AAC -0.4 0.006
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.37 0.04
mRNA RAF265 FIMM pan-cancer AAC -0.36 0.04
mRNA serdemetan FIMM pan-cancer AAC -0.34 0.03
mRNA Dasatinib FIMM pan-cancer AAC -0.33 0.05
mRNA Roscovitine FIMM pan-cancer AAC -0.31 0.07
mRNA Cyclopamine FIMM pan-cancer AAC -0.3 0.05
Download CSV